Targeted Single-cell Isolation of Spontaneously Escaping Live Melanoma Cells for Comparative Transcriptomics.


Journal

Cancer research communications
ISSN: 2767-9764
Titre abrégé: Cancer Res Commun
Pays: United States
ID NLM: 9918281580506676

Informations de publication

Date de publication:
08 2023
Historique:
received: 01 08 2022
revised: 30 05 2023
accepted: 12 07 2023
medline: 15 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Solid cancer cells escape the primary tumor mass by transitioning from an epithelial-like state to an invasive migratory state. As they escape, metastatic cancer cells employ interchangeable modes of invasion, transitioning between fibroblast-like mesenchymal movement to amoeboid migration, where cells display a rounded morphology and navigate the extracellular matrix in a protease-independent manner. However, the gene transcripts that orchestrate the switch between epithelial, mesenchymal, and amoeboid states remain incompletely mapped, mainly due to a lack of methodologies that allow the direct comparison of the transcriptomes of spontaneously invasive cancer cells in distinct migratory states. Here, we report a novel single-cell isolation technique that provides detailed three-dimensional data on melanoma growth and invasion, and enables the isolation of live, spontaneously invasive cancer cells with distinct morphologies and invasion parameters. Via the expression of a photoconvertible fluorescent protein, compact epithelial-like cells at the periphery of a melanoma mass, elongated cells in the process of leaving the mass, and rounded amoeboid cells invading away from the mass were tagged, isolated, and subjected to single-cell RNA sequencing. A total of 462 differentially expressed genes were identified, from which two candidate proteins were selected for further pharmacologic perturbation, yielding striking effects on tumor escape and invasion, in line with the predictions from the transcriptomics data. This work describes a novel, adaptable, and readily implementable method for the analysis of the earliest phases of tumor escape and metastasis, and its application to the identification of genes underpinning the invasiveness of malignant melanoma. This work describes a readily implementable method that allows for the isolation of individual live tumor cells of interest for downstream analyses, and provides the single-cell transcriptomes of melanoma cells at distinct invasive states, both of which open avenues for in-depth investigations into the transcriptional regulation of the earliest phases of metastasis.

Identifiants

pubmed: 37575281
doi: 10.1158/2767-9764.CRC-22-0305
pii: CRC-22-0305
pmc: PMC10416804
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1524-1537

Informations de copyright

© 2023 The Authors; Published by the American Association for Cancer Research.

Références

Trends Cell Biol. 2022 Mar;32(3):228-242
pubmed: 34836782
Nat Rev Mol Cell Biol. 2021 Aug;22(8):529-547
pubmed: 33990789
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Chem Biol. 2014 Jun 19;21(6):792-801
pubmed: 24816228
Genome Res. 2003 Aug;13(8):1863-72
pubmed: 12902380
J Leukoc Biol. 2011 May;89(5):661-7
pubmed: 21248150
Mol Med Rep. 2017 Sep;16(3):2397-2410
pubmed: 28713914
Nature. 2019 Sep;573(7774):434-438
pubmed: 31511694
Sci Data. 2020 May 27;7(1):160
pubmed: 32461585
Br J Pain. 2020 May;14(2):115-121
pubmed: 32537150
J Clin Anesth. 2015 Dec;27(8):672-9
pubmed: 26371714
Cancer Res. 2019 Sep 15;79(18):4557-4566
pubmed: 31350295
Nat Commun. 2016 Jul 08;7:12139
pubmed: 27387371
PLoS One. 2019 Apr 25;14(4):e0216042
pubmed: 31022259
Biotechniques. 2013 Oct;55(4):198-203
pubmed: 24107251
Nat Protoc. 2014 Jan;9(1):171-81
pubmed: 24385147
Dev Dyn. 2015 Jun;244(6):774-84
pubmed: 25809747
Analyst. 2019 Dec 2;144(24):7296-7309
pubmed: 31710321
Nature. 2020 Jun;582(7813):582-585
pubmed: 32581372
Cell Death Discov. 2021 Jan 18;7(1):14
pubmed: 33462196
Elife. 2021 Feb 23;10:
pubmed: 33620315
Leukemia. 2021 Jun;35(6):1539-1551
pubmed: 33707653
Nat Rev Mol Cell Biol. 2019 Dec;20(12):738-752
pubmed: 31582855
Mol Cell. 2017 Feb 16;65(4):631-643.e4
pubmed: 28212749
Cell Death Dis. 2020 Jun 11;11(6):448
pubmed: 32528057
Oncogene. 2021 Jan;40(2):322-333
pubmed: 33128042
Cancer Sci. 2019 Apr;110(4):1431-1441
pubmed: 30719824
Cell Death Differ. 2019 May;26(5):958-968
pubmed: 30154443
Anesthesiology. 2006 Oct;105(4):660-4
pubmed: 17006061
Genome Biol. 2014;15(12):550
pubmed: 25516281
Sci Data. 2018 Oct 02;5:180198
pubmed: 30277482
Cell Commun Signal. 2014 Apr 01;12:24
pubmed: 24690323
Oncol Rep. 2016 Nov;36(5):2579-2586
pubmed: 27665747
Development. 2015 Apr 1;142(7):1387
pubmed: 25804742
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Melanoma Res. 2000 Apr;10(2):165-9
pubmed: 10803717
Anesth Analg. 2008 Jul;107(1):325-32
pubmed: 18635504
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Sci Rep. 2018 Jun 7;8(1):8716
pubmed: 29880849
Arthritis Rheum. 2004 Jul;50(7):2130-9
pubmed: 15248210
Nat Protoc. 2007;2(8):2024-32
pubmed: 17703215
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Br J Anaesth. 2014 Oct 10;113(Suppl 1):i109-i116
pubmed: 25303989
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Mol Cell. 2019 Jul 25;75(2):372-381.e5
pubmed: 31126740
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Clin Med. 2017 Dec 22;7(1):
pubmed: 29271928
iScience. 2022 Mar 21;25(4):104130
pubmed: 35391830
Neoplasia. 2021 Feb;23(2):270-279
pubmed: 33465556
Elife. 2021 Aug 16;10:
pubmed: 34397384
Nat Commun. 2014 Jun 25;5:4255
pubmed: 24963846
Cell Mol Life Sci. 2010 Jan;67(1):63-71
pubmed: 19707854
Cancer Cell. 2011 Aug 16;20(2):229-45
pubmed: 21840487
Eur J Pharmacol. 1988 Jan 27;146(1):185-6
pubmed: 2832195
Breast Cancer Res. 2012 Oct 31;14(5):R139
pubmed: 23113900
Cancer Res. 2000 Oct 1;60(19):5401-4
pubmed: 11034079
Nat Cell Biol. 2003 Aug;5(8):711-9
pubmed: 12844144
BMC Biotechnol. 2003 Aug 12;3:13
pubmed: 12914671
Cancer Metab. 2021 Mar 16;9(1):11
pubmed: 33726850
iScience. 2020 Dec 26;24(1):101991
pubmed: 33490901

Auteurs

Jacqueline L E Tearle (JLE)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.
Present address: Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

Satya N V Arjunan (SNV)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.
Present address: Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.

Szun S Tay (SS)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.

Feyza Colakoglu (F)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.

James Cremasco (J)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.
Present address: Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

Matteo Golo (M)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.

Maté Biro (M)

EMBL Australia, Single Molecule Science node, School of Biomedical Sciences, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH